Fiche du document
- doi: 10.1016/j.hpb.2020.12.009
- issn: 1365-182X
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.hpb.2020.12.009
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/33485797
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/eissn/1477-2574
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_370816AAC59F6
info:eu-repo/semantics/openAccess , Copying allowed only for non-profit organizations , https://serval.unil.ch/disclaimer
Sujets proches
Complications and sequelaeCiter ce document
G. Longchamp et al., « Predictors of complications after liver surgery: a systematic review of the literature. », Serveur académique Lausannois, ID : 10.1016/j.hpb.2020.12.009
Métriques
Partage / Export
Résumé
Numerous potential predictors of adverse outcomes have been reported but their performance and utilization in practice seem heterogenous. This study aimed to systematically review the literature on the role and value of predictors of complications after hepatectomy. A systematic review following the PRISMA guidelines was performed. Studies on liver transplant were excluded. Only studies assessing overall or major complications were included. A total of 10'965 abstracts were screened. After application of exclusion criteria, 72 articles including 68'480 patients were included. A total of 72 markers with 48 pre-, 9 intra- and 15 postoperative factors were identified as predictors of complications. Preoperative and intraoperative predictive markers retrieved several times with the highest odds ratios (OR) were ASA score (OR range: 1.3-7.5, significant in 8 studies) and intraoperative need for red blood cell transfusion (OR range: 1.2-17.1, significant in 24 studies), respectively. Numerous markers have been described to predict the complication risk after hepatectomy. Because of their intrinsic characteristics, most markers such as ASA score and need for red blood cell transfusion are of limited clinical interest. There is a clear need to identify new biomarkers and to develop scores that could easily be implemented in clinical practice.